NCT02650063View on ClinicalTrials.gov

A Pharmacokinetic Study of DE-117 Ophthalmic Solution in Healthy Adult Male Subjects - Phase I Study -

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

March 31, 2016

Conditions
Healthy Male Adults
Interventions
DRUG

DE-117

Trial Locations (1)

Unknown

CPC Clinical Trial Hospital, Medipolis Medical Research Institute, Kagoshima

All Listed Sponsors
lead

Santen Pharmaceutical Co., Ltd.

INDUSTRY

NCT02650063 - A Pharmacokinetic Study of DE-117 Ophthalmic Solution in Healthy Adult Male Subjects - Phase I Study - | Biotech Hunter | Biotech Hunter